COVID-19: 'We might not be in a great spot in the fall,' says Moderna CEO
Moderna and other vaccine companies are anticipating waning immunity to become a concern.
"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told. "As you see more and more infectious variants ... We are not done with this virus mutating," he said. The biggest risk in the fall is the potential for hospitals to fill up with those that are the most vulnerable all over again, Bancel said.
The increased circulation from the intersection of waning immunity and a more transmissible variant, as is being observed with more Omicron subvariants in the U.S. and abroad, is the real risk, he said.
"We have a risk in the fall that we might not be in a great spot in the fall," Bancel said.
Meanwhile, increased global circulation also feeds into the sprouting of more variants.